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Purpose: Interferon regulation factor 5 (IRF5) is a member of the IRF family of transcription factors that control the
transactivation of type I interferon system-related genes as well as the expression of several other genes involved in immune
response. Here, we investigated its association with Behcet’s disease (BD) in a well defined group of Chinese Han patients.
Methods: A total of 152 unrelated Chinese patients with BD and 149 healthy blood donors were genotyped for IRF5
rs2280714  and  rs752637  polymorphisms.  Genomic  DNA  was  isolated  from  peripheral  blood  mononuclear  cells.
Genotyping of each single nucleotide polymorphism (SNPs) was performed by polymerase chain reaction restriction
fragment  length  polymorphism  (PCR-RFLP).  Allele  and  genotype  frequencies  of  IRF5  rs2280714  and  rs752637
polymorphisms were compared between patients and controls using a two-sided χ2 test.
Results: The results showed no significant difference concerning the frequency of the allele of rs2280714 and rs752637
polymorphisms between BD patients and the normal controls (p=0.647 and p=0.105, respectively). The frequencies of
the genotype of rs2280714 and rs752637 were not different between BD patients and the normal controls (p=0.233 and,
p=0.266, respectively). Clinical manifestation stratification analysis did not show any association of IRF5 polymorphisms
with BD patients (p>0.05).
Conclusions: Our study revealed that the rs2280714 and rs752637 SNPs were not associated with the susceptibility to
BD. There was no association between the two polymorphisms of IRF5 and any extraocular clinical manifestations in
BD.
Behcet’s disease (BD) is a chronic autoimmune disease
in which both genetic and environmental factors are involved.
It is a common uveitis entity in China, Japan, and the Middle
East countries [1]. BD is an autoimmune disease that results
from  damage  to  blood  vessels  throughout  the  body  [2].
However, what triggers this reaction is unclear.
The family of interferon regulatory factors (IRF) had
been  implicated  in  providing  a  principal  basis  for  host
resistance against pathogens [3]. The family also plays a role
in the regulation of the development of the immune system
and  the  production  of  pro-inflammatory  cytokine  [4-7].
Studies  have  demonstrated  that  IRF1  is  associated  with
Behcet’s  disease  [8]  whereas  IRF5  has  been  found  to  be
associated with certain autoimmune diseases such as systemic
lupus  erythematosus  (SLE)  [9,10],  inflammatory  bowel
disease  (IBD)  [11],  rheumatoid  arthritis  (RA)  [12],  and
multiple sclerosis (MS) [13]. Whether there is an association
of IRF5 with BD is not yet clear. Here, we examined the
association of IRF5 single polymorphisms (rs2280714 and
rs752637) with BD in a Chinese Han population.
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METHODS
Patients  and  normal  controls:  A  total  of  152  unrelated
Chinese patients with BD according to the international study
group criteria [14] and 149 age-, sex-, and ethnically-matched
healthy controls were included in this study. Samples from
patients and controls were genotyped for IRF5 rs2280714 and
rs752637 polymorphisms after they all gave their informed
consents. All study subjects were recruited from Zhongshan
Ophthalmic  Center  (Sun  Yat-sen  University,  Guangzhou,
P.R. China), the First Affiliated Hospital, Chongqing Medical
University (Chongqing, P.R. China), and Daping Hospital
(the  Third  Military  Medical  University,  Chongqing,  P.R.
China).  The  study  was  approved  by  the  local  ethics
committees  of  the  Third  Military  Medical  University  and
Chongqing Medical University.
Genomic  DNA  extraction  and  PCR:  Blood  samples  were
collected in ethylenediamine tetra acetic acid (EDTA) tubes
and kept at −70 °C until required [15]. Genomic DNA was
extracted from peripheral blood mononuclear cells, which was
performed  by  conventional  salting  of  cellular  protein,  an
alcohol precipitation using standard proteinase K digestion,
and  phenol  chloroform  extraction  procedure  [16].  We
amplified  the  target  DNA  in  IRF5  by  polymerase  chain
reaction (PCR) using the relevant primers. The primers of the
two remaining sites were designed using Primer Premier 5.0
software (Premier Biosoft International, Palo Alto, CA). The
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2018details  of  the  primers  and  enzymes  used  for  PCR-RFLP
genotyping are presented in Table 1.
Each PCR was performed in 10 μl of solution containing 5
μl premix Taq (Takara Biotechnology Co. Ltd, Dalian, P.R.
China), 10 pmol primers, and 0.2 μg of genomic DNA. The
cycling profile was: initial denaturation at 94 °C for 4 min, 45
cycles  consisting  of  94  °C  for  5  s,  proper  annealing
temperature 63 °C for 30 s, 72 °C for 30 s, and a final extension
for 4 min at 72 °C.
Genotyping:  Genotyping  of  each  single  nucleotide
polymorphism  (SNP)  was  performed  by  PCR  restriction
fragment length polymorphism (PCR–RFLP). PCR products
of rs2280714 and rs752637 were respectively digested with 2
μl of BSMFI, BCEAI restriction enzymes (Fermentas, MBI,
Vilnius,  Lithuania)  in  a  10  μl  reaction  volume  overnight.
Digestion products were visualized on agarose of 2%–3%
concentration and stained with GoldviewTM (SBS Genetech,
Beijing, P.R. China). BSMFI digestion of 130 bp PCR product
of  AA  genotype  gives  two  fragments,  the  GG  gives  one
fragment, and the AG gives three fragments. BCEAI digestion
of 120 bp PCR product of AA genotype gives two fragments,
the GG gives one fragment, and the AG gives three fragments.
To confirm the accuracy of the method employed, randomly
selected subjects (20% of all samples) were analyzed by direct
sequencing (Invitrogen Biotechnology Co., Guangzhou, P.R.
China). An appropriate control was included in each typing
run.
Statistical analysis: Allele and genotype frequencies of IRF5
rs2280714  and  rs752637  polymorphisms  were  compared
between  patients  and  controls.  Statistical  analysis  was
performed with the SPSS version 10.0 for Windows (SPSS
Inc., Chicago, IL). We evaluated the frequency of genotypes
and alleles in this study using the χ2 test. The association of
rs2280714 and rs752637 with the extraocular findings was
evaluated by logistic regression and statistical significance
was taken when p<0.05.
RESULTS
The average age of the BD patients was 32.7±6.4 years and
that of the healthy controls was 33.8±9.3 years. No statistical
difference in the distribution of age was observed between BD
patients and controls (p>0.05).
One  hundred  and  fifty-two  patients  and  one  hundred
forty-nine  normal  controls  were  genotyped  for  two  IRF5
SNPs. It is worthwhile to point out that some genotypes were
missing for controls for rs752637 SNPs due to insufficient
amount of DNA in some samples. The results showed that
there was no deviation from the Hardy–Weinberg equilibrium
(HWE). The genotype and allele frequencies of the rs2280714
SNPs in BD patients were not different from those in normal
controls  (p=0.233  and  p=0.647,  respectively;  Table  2).  A
similar result was found for rs752637 SNP versus normal
controls  (p=0.266  and  p=0.105,  respectively;  Table  2).
Stratification analysis according to oral ulcer, genital ulcer,
hypopyon,  skin  lesions,  and  arthritis  did  not  show  any
association of IRF5 polymorphisms with these parameters
(Table 3; p>0.05).
DISCUSSION
It has been demonstrated that both genetic and environmental
factors are involved in the development of BD [17]. In this
study, we investigated the association of IRF5 polymorphisms
TABLE 1. THE PRIMERS AND ENZYMES USED FOR PCR-RFLP GENOTYPING.
SNP Forward primer sequence Reverse primer sequence Enzyme
rs2280714 5′-CGTGGTCACATTGGTGATGCTC-3′ 5′-GGCTCTTCTCTCCAAGGCAGACA-3′ BSMFI
rs752637 5′-AAGGTGCCCAGAAAGAAGCTTCTTAC-3′ 5′-GCACTGGGAAATCACCCCTTTT-3′ BCEAI
The details of the primers and enzymes used for PCR-RFLP genotyping.
TABLE 2. GENOTYPE AND ALLELE DISTRIBUTIONS OF IRF5 RS2280714 AND RS752637 POLYMORPHISMS IN BD PATIENTS AND CONTROLS.
IRF5 SNPs Genotype allele Patients Normal controls p value OR (95%CI)
rs2280714 AA 51 (56.1) 60 (54.9) 0.233
  AG 74 (66.7) 58 (65.3) 0.233
  GG 27 (29.3) 31 (28.7) 0.233
  A 176 (57.9) 178 (59.7) 0.647 0.927 (0.670–1.283)
  G 128 (42.1) 120 (40.3) 0.647 1.079 (0.780–1.493)
rs752637 AA 64 (59.0) 49 (54.0) 0.266
  AG 68 (68.4) 63 (62.6) 0.266
  GG 20 (24.5) 27 (22.5) 0.266
  A 196 (64.5) 161 (57.9) 0.105 1.319 (0.944–1.843)
  G 108 (35.5) 117 (42.1) 0.105 0.758 (0.543–1.059)
BD=Behcet’s disease, OR=odds ratio, 95% CI=95% confidence interval. The genotype and allele distributions of IRF5
rs2280714 and rs752637 polymorphisms in BD patients and controls. No significant differences of the genotype and allele
distributions were found between patients and controls.
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2019with BD in the Chinese Han population. Our study showed
that rs2280714 and rs752637 were not associated with BD.
There was no association between the polymorphisms of IRF5
with any extraocular clinical manifestations.
BD  is  a  common  multisystem  inflammation  disorder
characterized by recurrent oral and genital ulceration, multiple
skin  lesions  and  uveitis  [18,19].  It  has  a  distinctive
geographical distribution. IRF5 has been shown to be strongly
associated  with  certain  autoimmune  diseases  in  different
ethnic populations [10,11,20,21] and to play a critical role in
the pathogenesis of autoimmunity [22]. Therefore, this gene
has  been  considered  as  a  general  susceptible  gene  for
autoimmune diseases. However, the genetic factors associated
with this disease in Chinese Han patients have been scarcely
studied. In this study, we focused on the association of two
SNPs of IRF5 with BD in the Chinese patients. As population
stratification may lead to a false-positive result in a case-
control study, we strictly selected the BD patients and controls
with  Chinese  Han  nationality.  To  validate  the  result  of
genotyping by PCR-RFLP, 20% of the samples were directly
sequenced.
Unfortunately,  in  this  study,  we  did  not  find  any
association of rs2280714 and rs752637 SNPs with BD. A
similar result was observed after stratification analysis based
on extraocular features. These results are not consistent with
those seen in other autoimmune diseases reported in European
and some other Asian populations [10,12,20,21]. This could
be explained by the fact that the etiology and pathogenesis of
BD may be different from those of the other autoimmune
diseases [2,18,19]. The other possibility could be that Chinese
Han people may have a different genetic background from
other ethnic populations [2,19]. Additionally, association of
some other IRF5 SNPs should be tested in BD.
Lee  and  coworkers  found  the  association  of  IRF1
polymorphism with Behcet’s disease in Koreans [8]. Here, we
failed  to  find  the  association  of  IRF5  with  BD.  The
inconsistent result can be explained by the different immune
function  of  IRF1  from  IRF5.  Both  of  them  interact  with
MyD88, an adaptor for multiple innate immune receptors, but
induce  a  distinctively  different  set  of  pro-inflammatory
cytokines. These results suggest that IRF1 and IRF5 play
different roles in the production of pro-inflammatory cytokine
and the regulation of the development immune system, that is
to say, different mechanisms may be induced by IRF1 than by
IRF5 in the development of BD disease.
In conclusion, our study revealed that the rs2280714 and
rs752637 SNPs were not associated with the susceptibility to
BD.  There  was  no  association  between  the  two
polymorphisms  of  IRF5  with  any  clinical  manifestations.
Further studies are needed to investigate the association of
other SNPs in IRF5 with BD.
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